Long Term Safety Follow-up of REMICADE (RESULTS).

Trial Profile

Long Term Safety Follow-up of REMICADE (RESULTS).

Phase of Trial: Phase IV

Latest Information Update: 09 May 2014

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease; Psoriasis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms RESULTS
  • Sponsors Centocor
  • Most Recent Events

    • 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top